AQEMIA is a physics‑based AI drug discovery company that leverages generative AI and deep physics to accelerate the creation of new medicines. Based in Paris and London, the firm offers a platform that integrates advanced computational models, high‑throughput simulations, and data‑driven pipelines to discover and optimize therapeutic candidates at scale. Their mission is to reinvent drug discovery by combining cutting‑edge science with AI to reduce time and cost, aiming to bring innovative treatments to patients faster.
AQEMIA is profiled on the APIs.io network. Tagged areas include Company, Artificial Intelligence, Drug Discovery, Biotechnology, and Platform.
Regulatory Posture applies to this provider. Its tags matched the
Horizontal (data, software, accessibility, platform) regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
Show this score on your site.
It updates itself when the score changes. Paste this where you link to your API docs:
<a href="https://apis.io/providers/aqemia/"><img src="https://apis.io/badge/aqemia/card.svg" alt="AQEMIA on APIs.io — Kin Score by API Evangelist"></a>
Other styles, a README pill and a shields.io endpoint are on the badge page.
Raise your score.
Agent readiness — checks not met, largest first (exact, from this profile):
Machine-Readable Auth+10 pts — a served openid-configuration/oauth-authorization-server carrying `issuer` (served), else the securitySchemes class in the provider OpenAPIs — bound (mutualTLS, DPoP, Signature) > negotiable (oauth2 authorizationCode/clientCredentials, openIdConnect) > bearer (http bearer, apiKey) Ask about this →
Idempotency+9 pts — OpenAPI mutating operations declare an idempotency key — a header, a request-body property, or a named de-duplication token whose own description says so (verified); else common[].type matches /idempoten/i (documented) Ask about this →
Stable Error Semantics+8 pts — OpenAPI $refs a shared error schema across 4xx/5xx responses (verified), else common[].type includes ErrorCatalog / ErrorCodes / DeclineCodes Ask about this →
13 more unmet checks in the Agent Readiness table above.
Kin Score — facets with the most composite points still available (weight × headroom):
Each check links to what satisfies it. Publish the artifact, or tell us where it already lives, and the score moves on the next scoring run.
Not sure how this applies to your stack? Ask about any one item. Kin Lane reads every question, looks at your profile and your situation, and replies with what a fix would take — scoped to that one area, priced up front, yours whether you ship it or not. Ask a question →
aid: aqemia
name: AQEMIA
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
probe_state: none
source:
- security
generated: '2026-11-13'
method: derived
image: https://aqemia.com/img/opengraph-image.png
description: AQEMIA is a physics‑based AI drug discovery company that leverages generative AI and deep physics to accelerate
the creation of new medicines. Based in Paris and London, the firm offers a platform that integrates advanced computational
models, high‑throughput simulations, and data‑driven pipelines to discover and optimize therapeutic candidates at scale.
Their mission is to reinvent drug discovery by combining cutting‑edge science with AI to reduce time and cost, aiming to
bring innovative treatments to patients faster.
url: https://raw.githubusercontent.com/api-evangelist/aqemia/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enrichment pass 2026-09-25 (modular-v1; was harvest)
specificationVersion: '0.20'
created: '2026-09-25'
modified: '2026-09-25'
tags:
- Company
- Artificial Intelligence
- Drug Discovery
- Biotechnology
- Platform
tags_raw:
- Company
- AI
- DrugDiscovery
- Biotechnology
- Platform
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: Hosts
url: hosts/aqemia-hosts.yml
- type: Vendors
url: vendors/aqemia-vendors.yml
- type: TermsOfService
url: https://aqemia.com/terms-of-use
- type: Newsroom
url: https://aqemia.com/news
- type: GitHubOrganization
url: https://github.com/Aqemia
- type: DomainSecurity
url: security/aqemia-domain-security.yml
- type: Website
url: https://aqemia.com/
- type: UsageTerms
url: terms/aqemia-terms-of-service.yml
- type: DataLicense
url: data-license/aqemia-data-license.yml
apis: []
x-coverage:
state: none
reason: no-developer-program
detail: No API developer program or public API documentation was found for AQEMIA.
evidence:
- url: https://api.aqemia.com/openapi.json
status: DNS_ERROR
checked: 2026-09-25
x-enrichment:
date: '2026-09-25'
status: enriched
artifacts_added: 4
pass: modular-v1
engine: identity=local,contract=local,surfaces=local,docs=local
Calls without X-API-Key need no key. Calls with it need a paid plan — get a key.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.